2013
DOI: 10.1118/1.4802735
|View full text |Cite
|
Sign up to set email alerts
|

First demonstration of intrafractional tumor‐tracked irradiation using 2D phantom MR images on a prototype linac‐MR

Abstract: The authors report the first demonstration of intrafractional tumor tracking using 2D MR images. During 2 min of tracking, the authors delivered highly conformal dose to a moving target that simulates tumor motions. Compared to static target irradiation, the 50% beam width remains essentially the same (within 0.5 mm), with an increase in 80%-20% penumbra width of less than 1.7 mm in moving target irradiation. These results illustrate potential dosimetric advantages of intrafractional MR tumor tracking in treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
78
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 67 publications
(80 citation statements)
references
References 53 publications
(62 reference statements)
2
78
0
Order By: Relevance
“…The major efforts include the ViewRay MRIdian MRI-60 Co solution, 20 the Cross Cancer Institute MRI-linac ("in-line" construction) 21 and the Elekta MRI-linac ("transverse" construction) 22 . The major advantage of MRI is superior soft tissue contrast, enabling accurate and robust deformable registrations.…”
Section: Daily In-room Treatment Imagingmentioning
confidence: 99%
“…The major efforts include the ViewRay MRIdian MRI-60 Co solution, 20 the Cross Cancer Institute MRI-linac ("in-line" construction) 21 and the Elekta MRI-linac ("transverse" construction) 22 . The major advantage of MRI is superior soft tissue contrast, enabling accurate and robust deformable registrations.…”
Section: Daily In-room Treatment Imagingmentioning
confidence: 99%
“…Several ambitious efforts are in progress to integrate MRI into a real‐time or near‐real‐time solution for tumor targeting during or immediately prior to radiation delivery. These efforts have produced a number of hybrid MRI‐RT solutions such as the Cross Cancer Institute MRI‐Linac prototypes at the University of Alberta,10 the Australian MRI‐Linac concept headed by Paul Keall's research group,11 the first commercialized Cobalt‐60/MRI solution from the company ViewRay12 and the pre‐commercial Elekta (Elekta AB, Stockholm, Sweden) MRI‐Linac 13…”
Section: Introductionmentioning
confidence: 99%
“…If the tumor is implanted with radiopaque fiducial markers, the position can be triangulated using stereoscopic imaging from two or more view angles [10][11][12][13] . Similarly, the tumor can be implanted with electromagnetic transponders 7,14 , or can be monitored in the treatment suite using MRI images 15 . One major drawback of these methods is that they rely on technologies or treatments not commonly available to the majority of radiotherapy centers, or are only available for use in certain tumor sites.…”
Section: Introductionmentioning
confidence: 99%